Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1
Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2022
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Miguel Martín, Christoph Zielinski, Manuel Ruiz-Borrego, et al.
Nature Communications
|
December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
Lesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2025
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study
Philippe L Bedard, Komal L Jhaveri, Melissa K Accordino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 22, 2020
Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease
Getahun Abate, Jack T Stapleton, Nadine Rouphael, et al.
Trials
|
January 11, 2024
Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial
Dheeraj Rai, Doug Webb, Amanda Lewis, et al.
The Lancet. Oncology
|
October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis
Daniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Faraday Discussions
|
August 23, 2024
Enzyme evolution, engineering and design: mechanism and dynamics: general discussion
Carlos Acevedo-Rocha, Lukasz Berlicki, Uwe T Bornscheuer, et al.
Faraday Discussions
|
August 27, 2024
Biocatalysis for industry, medicine and the circular economy: general discussion
Abdulrahman Alogaidi, Fraser Armstrong, Amulyasai Bakshi, et al.
JCO Precision Oncology
|
September 2, 2025
Reply to: Germline and Somatic <i>BRCA1/2</i> Mutations in Breast Cancer Treatment Strategies
Eric Hahnen, Jan Hauke, Karen Gelmon, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1
Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2022
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Miguel Martín, Christoph Zielinski, Manuel Ruiz-Borrego, et al.
Nature Communications
|
December 2, 2017
Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
Lesley-Ann Martin, Ricardo Ribas, Nikiana Simigdala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2025
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study
Philippe L Bedard, Komal L Jhaveri, Melissa K Accordino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 22, 2020
Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease
Getahun Abate, Jack T Stapleton, Nadine Rouphael, et al.
Trials
|
January 11, 2024
Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial
Dheeraj Rai, Doug Webb, Amanda Lewis, et al.
The Lancet. Oncology
|
October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis
Daniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Faraday Discussions
|
August 23, 2024
Enzyme evolution, engineering and design: mechanism and dynamics: general discussion
Carlos Acevedo-Rocha, Lukasz Berlicki, Uwe T Bornscheuer, et al.
Faraday Discussions
|
August 27, 2024
Biocatalysis for industry, medicine and the circular economy: general discussion
Abdulrahman Alogaidi, Fraser Armstrong, Amulyasai Bakshi, et al.
JCO Precision Oncology
|
September 2, 2025
Reply to: Germline and Somatic <i>BRCA1/2</i> Mutations in Breast Cancer Treatment Strategies
Eric Hahnen, Jan Hauke, Karen Gelmon, et al.
Page
of 14